DLD Asset Management »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by DLD Asset Management

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by DLD Asset Management from 13F filings

Historical chart of DLD Asset Management investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by DLD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by DLD Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $42M 30M 1.41
2025-06-30 $14M 13M 1.15

More positions owned by DLD Asset Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Centrus Energy Corp Cl A Put Option (LEU)
Echostar Corp Note 3.875%11/3 (Principal)
Bofa Fin MTNF 0.600% 5/2 (Principal)
Halozyme Therapeutics Note 1.000% 8/1 (Principal)
Ishares Tr Ishares Biotech Put Option (IBB)
Spirit Aerosystems Note 3.250%11/0 (Principal)
Makemytrip Limited Mauritius Note 2/1 (Principal)
Transocean Deb 4.625% 9/3 (Principal)
Progress Software Corp Note 1.000% 4/1 (Principal)
Ionis Pharmaceuticals Note 1.750% 6/1 (Principal)
Starwood Ppty Tr Note 6.750% 7/1 (Principal)
Dropbox Note 3/0 (Principal)
Rivian Automotive Com Cl A Put Option (RIVN)
Bristol Myers Squibb (BMY)

View all positions for DLD Asset Management

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Millennium Management
LMR Partners
Calamos Advisors
Camden Asset Management
Balyasny Asset Management
DLD Asset Management
Point72 Asset Management
Davidson Kempner Capital Management
Jpmorgan Chase & Co
Jain Global
Nuveen
Lazard Asset Management
State Street Corporation
Absolute Investment Advisers
Citadel Advisors

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1